Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this acquisition. With our shared commitment to creating the best ...

Jabil (JBL – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Ruplu Bhattacharya from Bank of America Securities reiterated a Buy rating on ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances ...